Larry L. Wood - Jul 5, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jul 5, 2022
Transactions value $
-$428,343
Form type
4
Date filed
7/5/2022, 08:59 PM
Previous filing
Jun 1, 2022
Next filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $266K +7.24K +3.58% $36.75 209K Jul 5, 2022 Direct F1
transaction EW Common Stock Sale -$694K -7.24K -3.46% $95.90 202K Jul 5, 2022 Direct F1, F2
holding EW Common Stock 496 Jul 5, 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7.24K -16.67% $0.00 36.2K Jul 5, 2022 Common Stock 7.24K $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $95.205 to $95.910. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.